Literature DB >> 8227723

Effects of ketoprofen on respiratory and circulatory changes in endotoxic shock.

G H Sigurdsson1, H A Youssef, A Banic.   

Abstract

OBJECTIVE: To study the effects of ketoprofen, a dual inhibitor of the arachidonic acid metabolism, on hemodynamic and respiratory changes during endotoxic shock.
DESIGN: Prospective, randomised, controlled study using an established intact animal model of endotoxic shock in sheep.
SETTING: An animal laboratory in a university hospital.
INTERVENTIONS: 4 groups were studied (n = 7 in each). Group K received ketoprofen and group A received aspirin 30 min before start of endotoxin infusion. Group E received endotoxin, but no drug treatment. Group C received neither endotoxin nor drug treatment. All the animals were anaesthetised with ketamine, had controlled ventilation with FiO2 = 0.5 and received Ringer's lactate at an infusion rate that would keep the pulmonary capillary wedge pressure constant.
RESULTS: Both ketoprofen and aspirin prevented the early rise in pulmonary arterial pressure that occurred in group E a few minutes after start of i.v. infusion of endotoxin. Furthermore, ketoprofen prevented any significant changes in arterial blood pressure, arterial oxygen tension, oxygen delivery index, oxygen extraction ratio, respiratory compliance, intrapulmonary shunt fraction, and platelet counts that occurred in group E. Aspirin, on the other hand, provided only partial and time limited (1-2 h) protection against these changes. Wet-to-dry weight ratios of the lungs were significantly lower in the ketoprofen treated than in the untreated shock controls and the aspirin treated animals.
CONCLUSION: Ketoprofen completely prevented the changes in hemodynamics and respiratory function observed in control-endotoxin-treated animals.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8227723     DOI: 10.1007/bf01694707

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  31 in total

Review 1.  Ketoprofen in oral surgery pain: a review.

Authors:  S A Cooper
Journal:  J Clin Pharmacol       Date:  1988-12       Impact factor: 3.126

Review 2.  Endotoxin and lung injury.

Authors:  K L Brigham; B Meyrick
Journal:  Am Rev Respir Dis       Date:  1986-05

3.  Relationship of TXB2 and 6-keto PGF1 alpha to the hemodynamic changes during baboon endotoxic shock.

Authors:  R H Harris; M Zmudka; Y Maddox; P W Ramwell; J R Fletcher
Journal:  Adv Prostaglandin Thromboxane Res       Date:  1980

4.  Intestinal platelet trapping after traumatic and septic shock. An early sign of sepsis and multiorgan failure in critically ill patients?

Authors:  G H Sigurdsson; J T Christenson; M B el-Rakshy; S Sadek
Journal:  Crit Care Med       Date:  1992-04       Impact factor: 7.598

5.  Prevention of the toxic action of tumor necrosis factor by cyclooxygenase inhibitor and leukopenia.

Authors:  F Goto; E Watanabe; N Maruyama; T Fujita
Journal:  Circ Shock       Date:  1989-11

Review 6.  Prostaglandin synthetase inhibitors in endotoxin or septic shock--a review.

Authors:  J R Fletcher
Journal:  Adv Shock Res       Date:  1983

7.  Inhibitory effects of non-steroidal anti-inflammatory drugs on superoxide generation.

Authors:  Y Yuda; J Tanaka; K Suzuki; K Igarashi; T Satoh
Journal:  Chem Pharm Bull (Tokyo)       Date:  1991-04       Impact factor: 1.645

8.  Induction of vascular injury by Pseudomonas aeruginosa cytotoxin in rabbit lungs is associated with the generation of different leukotrienes and hydroxyeicosatetraenoic acids.

Authors:  F Grimminger; D Walmrath; H Walter; F Lutz; W Seeger
Journal:  J Infect Dis       Date:  1991-02       Impact factor: 5.226

9.  Ibuprofen plus prostaglandin E1 in a septic porcine model of adult respiratory distress syndrome.

Authors:  E A Davies; A J Campbell; M J Devine; S M Steinberg; C T Cloutier
Journal:  J Trauma       Date:  1989-03

10.  Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation.

Authors:  B Samuelsson
Journal:  Science       Date:  1983-05-06       Impact factor: 47.728

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.